Cutaneous Squamous Cell Carcinoma (cSCC)

British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020

Guidelines

Gold standard: skin biopsy for histology
  • Preferred: full thickness incisional biopsy (containing both peripheral and deep margins)
  • Large / anatomically challenging area → incisional (punch) biopsy

1st line: standard surgical excision (in resectable primary disease)
 
Consider  Mohs micrographic surgery after MDT if:
  • Tumour margin are not clearly visible / well-defined
  • At sites where tissue conservation is important (e.g. eyelid, lips, ears, fingers, genitalia)
  • At cosmetically sensitive areas (e.g face)
 
If surgery not appropriate: primary radiotherapy is an option
 

Peripheral surgical margins (determined under magnification / dermoscopy):
  • Low risk tumour → ≥4mm margin
  • High risk tumour → ≥6mm margin
  • Very high risk tumour → ≥10mm margin

Also ensure at least 1mm histological clearance at all margins.

Low Risk High Risk Very High Risk
ALL the following must be met ANY of the following ANY of the following
  • Diameter ≤20mm (pT1)
  • Thickness ≤4mm
 
  • Invasion to dermis only
  • No perineural invasion
  • No lymphovascular invasion
  • Histology: well or moderately differentiated
  • Diameter: 20-40mm (pT2)
  • Thickness 4-6mm
 
  • Invasion to subcutaneous fat
  • Perineural invasion (dermal only)
  • Histology: poorly differentiated
  • Lymphovascular invasion
  • Tumour at ear or lip
  • Tumour arising within scar or area of chronic inflammation (i.e. Marjolin's ulcer)
  • Diameter >40mm (pT3)
  • Thickness >6mm
 
  • Invasion beyond subcutaneous fat
  • Any bone invasion
  • Perineural invasion (nerve ≥0.1mm or nerve beyond dermis or in named nerve)
  • Histology: high grade subtype (adenosquamous, desmoplastic, spindle / sarcomatoid / metaplastic)
  • In-transit metastasis
 
Author: Adams Lau
Reviewer:
Last edited: 15/07/25